---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-24-001929"
form_type: "8-K"
ticker: null
cik: "0001923840"
company_name: "Third Harmonic Bio, Inc."
filed_at: "2024-01-04T23:59:59+00:00"
generated_at: "2026-06-07T04:17:58.787851+00:00"
event_type: "leadership"
sentiment: "positive"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# THRD appoints new CFO, provides THB335 update; IND filing on track for H1 2024

## Summary
- Christopher M. Murphy appointed CFO and Business Officer effective Jan 4, 2024; base salary $495K, annual bonus up to 40%, option for 410,000 shares.
- Murphy previously held leadership roles at Horizon Therapeutics, including Group VP Commercial Operations and Business Development.
- THB335 IND-enabling toxicology studies nearing completion; pre-IND FDA interaction complete.
- Company on track to file U.S. IND and initiate Phase 1 SAD/14-day MAD study in first half of 2024.
- Cash and cash equivalents $273.9M as of Sept 30, 2023; strong financial position.

## SEC filing metadata
- accession: 0001193125-24-001929
- form_type: 8-K
- cik: 0001923840
- company_name: Third Harmonic Bio, Inc.
- filed_at: 2024-01-04T23:59:59+00:00
- event_type: leadership
- sentiment: positive
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 5.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1923840/000119312524001929/0001193125-24-001929-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1923840/000119312524001929/d107873d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-24-001929
- JSON: https://secwatch.observer/filing/0001193125-24-001929.json
- Plain text: https://secwatch.observer/filing/0001193125-24-001929.txt

## Key facts
- Executive change
  Christopher M. Murphy was appointed as Chief Financial and Business Officer at Third Harmonic Bio, Inc..
  - Action: appointed
  - Role: Chief Financial and Business Officer
  source text: On January 4, 2024, Third Harmonic Bio, Inc. (the “ Company ”), announced the appointment of Christopher M. Murphy, age 40, as the Company’s Chief Financial and Business Officer and principal financial officer, effective as of January 4, 2024.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1923840/000119312524001929/0001193125-24-001929-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.